GDS Wealth Management Raises Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

GDS Wealth Management boosted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 43.6% in the 4th quarter, Holdings Channel reports. The firm owned 41,131 shares of the company’s stock after purchasing an additional 12,493 shares during the period. GDS Wealth Management’s holdings in HealthEquity were worth $3,947,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of HQY. Bank of Montreal Can raised its position in HealthEquity by 10.5% in the 2nd quarter. Bank of Montreal Can now owns 11,308 shares of the company’s stock valued at $976,000 after purchasing an additional 1,077 shares during the last quarter. Creative Planning increased its stake in HealthEquity by 25.0% in the 2nd quarter. Creative Planning now owns 19,926 shares of the company’s stock valued at $1,718,000 after buying an additional 3,983 shares during the period. Truist Financial Corp increased its stake in HealthEquity by 7.0% in the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock valued at $247,000 after buying an additional 188 shares during the period. SG Americas Securities LLC increased its stake in HealthEquity by 207.3% in the 3rd quarter. SG Americas Securities LLC now owns 11,671 shares of the company’s stock valued at $955,000 after buying an additional 7,873 shares during the period. Finally, Handelsbanken Fonder AB grew its stake in shares of HealthEquity by 19.7% during the 3rd quarter. Handelsbanken Fonder AB now owns 20,616 shares of the company’s stock worth $1,687,000 after purchasing an additional 3,400 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Down 0.1 %

Shares of NASDAQ HQY opened at $110.31 on Tuesday. The stock has a market cap of $9.56 billion, a price-to-earnings ratio of 101.20, a PEG ratio of 1.94 and a beta of 0.54. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The business has a 50 day simple moving average of $100.22 and a 200 day simple moving average of $88.75. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $112.53.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the prior year, the firm posted $0.40 EPS. On average, research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In related news, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the completion of the transaction, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,289 shares of company stock worth $3,355,718 over the last three months. 2.20% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

HQY has been the topic of several recent research reports. BTIG Research boosted their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. Barrington Research lifted their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. Bank of America lifted their price target on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Mizuho initiated coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. Finally, JMP Securities upped their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $110.71.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.